TCS Agentic AI: Boosting Drug Development Efficiency

Tata Consultancy Services, or TCS, is introducing audit-ready Agentic AI for global drug development. This new platform, called TCS ADD AgentHub, aims to help pharmaceutical companies use AI while meeting strict regulatory and compliance demands. Here's the thing: drug development often faces delays due to operational complexity, not just scientific discovery. This is especially true in highly regulated environments. What's interesting is that AgentHub uses AI Workers, Assistants, and Tools to handle tasks like medical coding, quality review, and study support. These AI agents work alongside human experts, not replacing them, and operate within a framework of human oversight and lifecycle control. TCS reports that early deployments have shown significant results. AgentHub has delivered up to 40% efficiency gains in clinical data management. There's also been up to a 30% reduction in clinical study build effort and up to 30% cost savings in processing Individual Case Safety Reports. The bottom line is this technology helps experts focus on higher-value scientific and medical decisions by reducing repetitive manual work.